Rectitude Holdings, Ltd. (NASDAQ:RECT – Get Free Report) saw a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 9,200 shares, an increase of 19.5% from the October 15th total of 7,700 shares. Approximately 0.4% of the company’s stock are sold short. Based on an average daily volume of 9,800 shares, the days-to-cover ratio is currently 0.9 days.
Rectitude Price Performance
RECT stock traded down $0.06 during mid-day trading on Friday, reaching $3.44. The company had a trading volume of 8,414 shares, compared to its average volume of 8,024. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.86 and a quick ratio of 1.37. The company has a fifty day moving average of $3.28. Rectitude has a fifty-two week low of $2.70 and a fifty-two week high of $4.25.
Institutional Trading of Rectitude
A hedge fund recently bought a new stake in Rectitude stock. Frank Rimerman Advisors LLC acquired a new position in shares of Rectitude Holdings, Ltd. (NASDAQ:RECT – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 14,000 shares of the company’s stock, valued at approximately $46,000. Frank Rimerman Advisors LLC owned about 0.10% of Rectitude at the end of the most recent quarter.
About Rectitude
Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, gloves, safety footwear, personal fall arrest systems, portable fire extinguishers and traffic products. The Company also offers auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.
See Also
- Five stocks we like better than Rectitude
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Rectitude Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rectitude and related companies with MarketBeat.com's FREE daily email newsletter.